Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current treatment practice in immunosuppression.

G Ciancio1, G W Burke, J Miller

  • 1Department of Surgery, Division of Transplantation, University of Miami School of Medicine, PO Box 012440, Miami, Fl. 33101, USA. gciancio@med.miami.edu

Expert Opinion on Pharmacotherapy
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of sacroiliitis on magnetic resonance enterography in Crohn's disease and its association with intestinal findings: a monocentric observational cross-sectional study.

Clinical and experimental medicine·2025
Same author

Corrigendum to 'Partial Bladder Transplantation with En Bloc Kidney Transplant-The First Case Report of a 'Bladder Patch Technique' in a Human' [American Journal of Transplantation 8 (2008) 1060-1063].

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2024
Same author

Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer.

Reumatismo·2022
Same author

Erythema nodosum after COVID-19 vaccine.

Reumatismo·2022
Same author

Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis.

Reumatismo·2021
Same author

Risk factors, management, and survival of bladder cancer after kidney transplantation.

Actas urologicas espanolas·2021
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

New immunosuppressive drugs are emerging in solid organ transplantation, potentially replacing long-standing treatments like cyclosporin and azathioprine. Tacrolimus and mycophenolate mofetil represent significant advancements in transplant therapy.

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation Medicine

Background:

  • Cyclosporin has been a dominant immunosuppressant in solid organ transplantation for over two decades.
  • Azathioprine has been a standard immunosuppressive agent for 35 years.
  • The development of novel immunosuppressive agents is crucial for improving transplant outcomes.

Purpose of the Study:

  • To review recent advancements in immunosuppressive drug development for solid organ transplantation.
  • To highlight emerging therapies that may supersede current standards of care.

Main Methods:

  • Review of recently introduced and experimental immunosuppressive agents.
  • Analysis of their mechanisms of action and clinical applications in transplantation.

Related Experiment Videos

Main Results:

  • Tacrolimus (FK506) has been introduced as a potent immunosuppressant, particularly for liver transplants.
  • Mycophenolate mofetil (MMF), a mycophenolic acid derivative, is emerging as a replacement for azathioprine.
  • Other novel purine and pyrimidine biosynthesis inhibitors are under investigation.

Conclusions:

  • New immunosuppressive drugs, including tacrolimus and MMF, are poised to change the landscape of solid organ transplantation.
  • Ongoing research into novel agents targeting immune pathways promises further advancements in transplant therapy.